ArticlePloS one

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM.

Hyunkyung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.